International Flavors & Fragrances stock launches a dairy enzyme

Published on 10/04/2026 at 19:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

International Flavors & Fragrances stock was last at USD 82.42 on October 2, 2026 after IFF launched a dairy enzyme product. Adjusted Q2 EPS was USD 0.82 versus USD 1.14 consensus.

Extreme Makro-Detailaufnahme von Rosenblättern, Vanilleschoten und Sternanis auf Schwarz — International Flavors & Fragrances US4595061015 Makro-Aufnahme botanischer Aromazutaten Vanille Sternanis und Rosenblütenblätter, Illustration mit AI erstellt.

International Flavors & Fragrances Inc. (ISIN US4595061015) was last at USD 82.42 on the NYSE on October 2, 2026 at 4:00 p.m. ET, down 0.84 percent from the prior close. The company launched Omni-Bos PHY, a phytase enzyme for dairy cattle, in an announcement dated September 17, 2026, according to Business Wire.

Dairy enzyme targets feed efficiency

Omni-Bos PHY is designed to help dairy producers unlock nutrients already present in feed and improve nutrient utilization. IFF said the initial rollout covers the Middle East, Africa and Asia-Pacific, giving the Health and Biosciences business a product launch tied to animal nutrition.

Testing cited in the release found that the enzyme reduced undegraded phytate in the rumen by 70 percent versus a control diet. Additional trials in lactating dairy cows reported improved phosphorus and phytate digestibility, lower nitrogen and phosphorus excretion, and better digestibility of crude protein and calcium.

Q2 earnings missed estimates

IFF's second-quarter 2026 results provide a tougher financial counterpoint. According to Yahoo Finance on September 16, 2026, adjusted EPS was USD 0.82 against USD 1.14 expected, while revenue was USD 2.0 billion against a USD 2.7 billion forecast. IFF's full-year 2026 revenue guidance was USD 7.4 billion to USD 7.6 billion.

The standardized Q2 2026 figures show revenue of USD 1.954 billion, diluted GAAP EPS of USD 0.20, net income of USD 33.0 million and operating margin of 8.0 percent for the period ended June 30, 2026. The distinction between adjusted EPS and GAAP EPS matters because the adjusted result is the figure used in the market comparison.

Analysts see room above USD 82.42

According to MarketBeat on September 30, 2026, 19 brokerages held a Moderate Buy consensus, with 12 Buy ratings and seven Holds. The average 12-month price target was USD 91.40, which lies 10.9 percent above the October 2 price.

Investing.com lists November 9, 2026 as IFF's next earnings date. That report will put the USD 7.4 billion to USD 7.6 billion sales outlook against the company's ability to convert new product activity into improved earnings.

IFF stock stays below its yearly high

IFF stock was last at USD 82.42 on the NYSE on October 2, 2026 at 4:00 p.m. ET. The session range was USD 82.41 to USD 84.17, the 52-week range was USD 59.14 to USD 89.31, market capitalization was USD 21.0 billion, and volume was 1,853,855 shares.